Viewing Study NCT02260934


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-02-08 @ 2:31 PM
Study NCT ID: NCT02260934
Status: COMPLETED
Last Update Posted: 2020-12-01
First Post: 2014-10-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab and Belimumab for Lupus Nephritis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Nephritis View
Keywords: